London Drugs · EDI 810

The London Drugs 810 Invoice, explained

What London Drugs expects in the 810 — your bill for the shipment. Must reconcile with the PO and the ASN — and how EDISQ's certified map handles it from your ERP.

Connect to London Drugs free 810 glossary guide

What London Drugs expects in the 810

London Drugs trades on X12 4010 over AS2. Beyond the base standard, watch these:

Matchinvoice ties to the PO line and the receipt
TaxCanadian GST/PST detail carried in the invoice tax segments

How EDISQ maps it

The certified London Drugs 810 map loads when you enable the partner — fields auto-map from NetSuite, QuickBooks, Dynamics, and 33 other systems, validation runs against London Drugs's spec before transmission, and the sandbox replays London Drugs test scenarios until everything passes.

Common rejection reasons

Nearly all 810 rejections trace to reference data, not syntax: identifiers that don't match London Drugs's cross-references, echoed fields dropped from the original PO, or timing that misses the program window. EDISQ flags each before London Drugs ever sees the document.

Sample London Drugs 810

A representative 810 interchange addressed to London Drugs — envelope, body segments, and control totals:

1ISA*00*          *00*          *ZZ*ACMESUPPLY     *ZZ*LONDONDRUGS    *260101*1200*U*00401*000000001*0*P*>~
2GS*IN*ACMESUPPLY*LONDONDRUGS*20260101*1200*1*X*004010~
3ST*810*0001~
4BIG*20260107*INV10001*20260101*PO12345~
5REF*DP*056~
6N1*ST*LONDON DRUGS DC 5093*92*5093~
7IT1*1*24*EA*9.75**UP*012345678905~
8IT1*2*12*EA*14.50**UP*012345678912~
9TDS*40800~
10CTT*2~
11SE*9*0001~
12GE*1*1~
13IEA*1*000000001~

FAQ

Which 810 version does London Drugs use?

X12 4010, delivered over AS2. The certified map tracks London Drugs's current companion guide.

How do I test a London Drugs 810?

The sandbox generates realistic London Drugs 810 scenarios against your live mapping — free, unlimited, invisible to London Drugs.

What does it cost?

Per document only: first 25/month free, then from $0.50, decreasing with volume. No partner or mapping fees.